Clinical efficacy of Jingyin granules, a Chinese patent medicine, in treating patients infected with coronavirus disease 2019

BACKGROUND: Jingyin granules (JY), one patented Chinese herbal formula, have been advised for treating coronavirus disease 2019 (COVID-19) in China. As of now, the safety and effectiveness of JY in treating COVID-19 patients were still to be evaluated. PURPOSE: To investigate the safety and clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Bowu, Yu, Xiaoxiao, Zhang, Lei, Huang, Wenqi, Lyu, Hua, Xu, Yuping, Shen, Jiaojiao, Yuan, Weian, Fang, Min, Li, Man, Gao, Yueqiu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier GmbH. 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9575312/
https://www.ncbi.nlm.nih.gov/pubmed/36288651
http://dx.doi.org/10.1016/j.phymed.2022.154496

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9575312/
https://www.ncbi.nlm.nih.gov/pubmed/36288651
http://dx.doi.org/10.1016/j.phymed.2022.154496

Ejemplares similares